Author

D Klímová

Observed names: D. A. Klimova, Daria Klimova

Observed institutions: Russian Cancer Research Center NN Blokhin, Ministry of Health of the Russian Federation

ORCID: 0000-0001-6241-1866

Observed ORCID: 0000-0001-6241-1866

OpenAlex ID: A5037456997

The role of АВС transporters in drug resistance to bortezomib in multiple myeloma

2019 · L. A. Laletina, N. I. Moiseeva, et al. · Advances in molecular oncology · 4

A phase Ib, window-of-opportunity study of neoadjuvant avelumab and hypofractionated proton beam therapy for recurrent radiation-relapsed meningioma.

2024 · Jiayi Huang, Jian Li Campian, et al. · Journal of Clinical Oncology · 1

A phase I window-of-opportunity study of neoadjuvant avelumab and hypofractionated radiation therapy in radiation-relapsed meningioma

2025 · Jiayi Huang, Tanner M. Johanns, et al. · medRxiv

[Serum interleukin-6 in multiple myeloma: I. Relation to selected laboratory indicators of disease].

1995 · V Scudla, J Bacovský, et al. · PubMed

[Serum thymidine kinase in multiple myeloma: II. Relation to disease activity and stage].

1994 · V Scudla, T Papajík, et al. · PubMed

[Is kidney transplantation really advantageous for the compensated dialyzed patient?].

1985 · R Recková, D Klímová · PubMed

[Connecting patients with chronic kidney failure to the artificial kidney. 10 years' experience at the Strahov Hemodialysis Center].

1983 · D Klímová, V Vanĕcek · PubMed

[Continuous peritoneal dialysis (author's transl)].

1981 · A Válek, R Kuklík, et al. · PubMed

Works count: 8

Citation count: 5

H-index: 1

I10-index: